Blood thinner showdown: which single drug works best after stents?
NCT ID NCT06691191
First seen Feb 05, 2026
Summary
This study compares two blood thinners, prasugrel and ticagrelor, when used alone after stopping aspirin in people with coronary artery disease who have had a stent placed. About 48 participants will take one of the two drugs for three weeks to see which one better prevents blood clotting. The goal is to find out if one drug is as good as or better than the other when used by itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Florida Jacksonville
RECRUITINGJacksonville, Florida, 32209, United States
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
prasugrel and ticagrelor (blood thinners)
What this could lead to
If successful, this could show that one of these blood thinners works better than the other when used alone, potentially simplifying treatment after stent placement.
What could go wrong
This is a small, early-phase study with only 48 participants, so results may not apply to everyone. It measures lab effects, not real-world outcomes like heart attacks or strokes.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.